Evidence map›Paper›PMID 28054028›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2016

The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism.

Eddie Stage, Tugce Duran, Shannon L Risacher, Naira Goukasian, Triet M Do, John D West, Holly Wilhalme, Kwangsik Nho, Meredith Phillips, David Elashoff and 2 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Science advances · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Controlling the Impact ofMedicina (Kaunas, Lithuania) · 2023
    Article
  12. Review
  13. Alzheimer's Disease: An Updated Overview of Its Genetics.International journal of molecular sciences · 2023
    Review
  14. Regulation of KInternational journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases.Frontiers in cell and developmental biology · 2022
    Review
  18. Association of the top 20 Alzheimer's disease risk genes with [Alzheimer's & dementia (Amsterdam, Netherlands) · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eddie StageDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Tugce DuranDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Shannon L RisacherDepartment of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
Naira GoukasianDepartment of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Triet M DoDepartment of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
John D WestDepartment of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
Holly WilhalmeDepartment of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Kwangsik NhoDepartment of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
Meredith PhillipsDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
David ElashoffDepartment of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Andrew J SaykinDepartment of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Indiana University Network Science Institute, Indianapolis, IN, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Liana G ApostolovaDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana University School of MedicineUniversity of California, Los Angeles · USIndiana University – Purdue University Indianapolis · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Memory Circuitry in MCI and Early Alzheimer’s Disease Prodrome: Molecular DriversR01AG019771 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 2001 to 2021
$6.9M
Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex DiseaseR01LM012535 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI NHO, KWANGSIK TIMOTHY · 2017 to 2021
$1.7M
Imaging and genetic biomarkers for Alzheimer's diseaseR01AG040770 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI APOSTOLOVA, LIANA G · 2012 to 2016
$1.4M
Structural MRI outcome predictors in MCIK23AG026803 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI APOSTOLOVA, LIANA G · 2005 to 2009
$864k
Integration of Bio-, Medical, and Imaging Informatics for Complex DiseasesR00LM011384 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI NHO, KWANGSIK TIMOTHY · 2013 to 2015
$647k
Sensory and Perceptual Measures as Biomarkers of Alzheimer's Disease PathologyK01AG049050 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI RISACHER, SHANNON L · 2015 to 2019
$612k
Imaging epigenetics of Alzheimer's DiseaseK02AG048240 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI APOSTOLOVA, LIANA G · 2014 to 2016
$434k
Neurogenesis in Adult Brain: Gene Networks and Alzheimer’s DiseaseR03AG054936 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI NHO, KWANGSIK TIMOTHY · 2017 to 2018
$145k
Integration of Bio-, Medical, and Imaging Informatics for Complex DiseasesK99LM011384 · NLM · INDIANA UNIVERSITY INDIANAPOLIS · PI NHO, KWANGSIK TIMOTHY · 2012 to 2012
$90k
NIA NIH HHS K01 AG049050NIA NIH HHS K02 AG048240NIA NIH HHS K23 AG026803NIA NIH HHS P30 AG010133NIA NIH HHS R01 AG019771NIA NIH HHS R01 AG040770NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG021886NLM NIH HHS K99 LM011384NLM NIH HHS R00 LM011384NLM NIH HHS R01 LM012535
6 · The paper itself

Abstract

introductionWe analyzed the effects of the top 20 Alzheimer disease (AD) risk genes on gray-matter density (GMD) and metabolism.

methodsWe ran stepwise linear regression analysis using posterior cingulate hypometabolism and medial temporal GMD as outcomes and all risk variants as predictors while controlling for age, gender, and

resultsSignificant predictors of brain GMD were DISCUSSION: Multiple variants showed associations with GMD and brain metabolism. For most genes, the effects were limited to specific stages of the cognitive continuum, indicating that the genetic influences on brain metabolism and GMD in AD are complex and stage dependent.

Indexed as

ADADNIAlzheimer diseaseAtrophyBrain mappingBrain metabolismFluorodeoxyglucose positron emission tomography (FDG PET)Genetic variationGenome-wide association studies (GWAS)Imaging geneticsMagnetic resonance imaging (MRI)Positron emission tomography (PET)Risk genesStatistical parametric mapping (SPM)

Identifiers

PMID28054028
PMCPMC5198883
OpenAlexW2563770392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.